Delivery Order SPE2DB25D3005-SPE2DB25FQBKE

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,534.49 Firm Fixed Price Delivery Order is for the supply of KENALOG-40 200 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024 and was awarded on December 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, to provide a variety of pharmaceutical products and medical supplies. The $1,874.70 firm fixed price delivery order is for the supply of 4565152600 KENALOG-40 200 MG/5 ML VIAL 5ML. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,040.74 firm fixed-price delivery order is for the supply of KENALOG-40 200 MG/5 ML VIAL 5ML, a specialty pharmaceutical product. The contract has a completion date of September 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of KENALOG-40 200 MG/5 ML VIAL 5ML. The $2,158.62 Firm Fixed Price Delivery Order does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The $1,166.12 firm fixed price contract is for the delivery of 4564815497 KENALOG-40 200 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract has no set-aside designation and is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,928.00 firm fixed price delivery order is for the supply of KENALOG-40 400 MG/10 ML VIAL 10ML, a prescription medication. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,061.71 firm fixed price delivery order is for the supply of 4565078159 KENALOG-40 200 MG/5 ML VIAL 5ML, with a completion date of July 8, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is fulfilling this order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,569.56 firm fixed-price delivery order is for the supply of KENALOG-40 200 MG/5 ML VIAL 5ML, a corticosteroid medication, to support federal healthcare programs. The award has an ultimate completion date of September 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,101.88 firm fixed-price delivery order is for KENALOG-40 200 MG/5 ML VIAL 5ML, with a period of performance ending on October 29, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of KENALOG-40 200 MG/5 ML VIAL 5ML, a pharmaceutical product, with a ceiling value of $2,290.79 and a performance period through April 9, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQBKE
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,480.35, is a delivery order for the pharmaceutical product KENALOG-40 400 MG/10 ML VIAL 10ML. The contract has an ultimate completion date of January 6, 2025 and is a firm fixed-price contract type.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The contract award is associated with this larger IDC vehicle with the DLA.

Generated 4/4/25, 10:05 AM